Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP The AIRCULES phase 2b study ...
Healio

Confront asthma myths to improve patient outcomes

Please provide your email address to receive an email when new articles are posted on . Many parents believe children will outgrow wheeze without seeing a specialist. Many patients also underestimate ...
The Cardiology Advisor

Asthma in Older Age Linked to Other Comorbidities

Asthma in older age is associated with significantly higher rates of depression, cognitive decline, and multimorbidity.
Zacks Investment Research on MSN

SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema

Sanofi SNY announced positive data from two separate mid-stage studies (AIRCULES and DUET) evaluating the safety and efficacy of its investigational candidate, lunsekimig, in patients with moderate-to ...